FDA Adverse Event Injury Summary report: N

BALL HEADS: MECTACER HEAD BIOLOX OPTION Ø 28

MDR report key: 20005705 · Received August 20, 2024

Report

Report Number
3005180920-2024-00649
Event Type
Injury
Date Received
August 20, 2024
Date of Event
July 23, 2024
Report Date
August 20, 2024
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
UDI-DI
07630030809323
PMA / PMN Number
K131518
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 31 JULY 2024. LOT 2348073: (B)(4) MANUFACTURED AND RELEASED ON 09-JAN-2024. EXPIRATION DATE: 2028-12-11. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ADDITIONAL COMPONENT INVOLVED IN THE EVENT: STEM: MASTERLOC 01.39.203 CEMENTLESS TI COATED LAT STEM SIZE 3 (K160289) LOT 2112247: (B)(4) MANUFACTURED AND RELEASED ON 10-JAN-2022. EXPIRATION DATE: 2026-12-21. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW.STEM:

Description of Event or Problem · 0

THE PATIENT HAD A PRIMARY HIP SURGERY ON (B)(6) 2014. ON (B)(6) 2024 SHELL, HEAD AND LINER WERE REVISED SUCCESSFULLY. THE PATIENT LUXATED HIS HIP AND SUSTAINED A CLOSED REDUCTION, BUT AFTER THIS, IN THE X-RAYS DONE IN THE ER, IT WAS NOTICED THAT THE SHELL WAS OUT OF THE ACETABULUM BONE. IT IS UNKNOWN IF THE LUXATION WAS DUE TO THE CUP FAILURE OR IF THE CUP FAILURE WAS GENERATED DURING THE CLOSED REDUCTION. PRESENTLY, THE PATIENT CAME IN DUE TO SIGNS OF INFECTION AND THE PATHOGEN IS UNKNOWN. THE SURGEON PERFORMED A WASHOUT, EXPLANTED ALL IMPLANTS AND PLACED AN ANTIBIOTIC SPACER. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2361928 BALL HEADS: MECTACER HEAD BIOLOX OPTION Ø 28 HIP FEMORAL HEAD LZO MEDACTA INTERNATIONAL SA 2348073 07630030809323

Patients

Seq Age Sex Outcome Treatment
1 46 YR Female Required Intervention